Article Details
Retrieved on: 2025-06-24 17:05:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Developed by Chugai, part of the Roche Group, NXT007 is an investigational drug that promotes haemostatic normalisation in patients without factor ...
Article found on: www.worldpharmaceuticals.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here